S1P induces the activation of extracellular signal-regulated kinase 1/2 (ERK1/2) enzymes, which subsequently activate the S1P receptor (S1PR) on the surface of cancer cells, leading to enhanced cancer cell proliferation, (Fig. 4), [76]. This evidence concerns the gene MAPK3 and cancer.